Effectiveness of Conservative Treatment in Patients With Thoracic and Lumbar Fractures Without Neurological Deficit

NCT ID: NCT06059820

Last Updated: 2025-10-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-11-01

Study Completion Date

2025-09-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to compare the long-term clinical outcomes of two treatment methods (conservative therapy and surgical treatment) in patients with fractures of the thoracic and lumbar spine without neurological deficit

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The main objectives of the upcoming study include:

* to conduct a retrospective analysis of the surgical treatment outcomes in patients with thoracic or lumbar vertebral fractures;
* to assess the immediate and long-term outcomes of conservative therapy in patients with thoracic or lumbar vertebral injuries;
* to evaluate the overall cost of surgical and conservative treatment one year post-discharge, as well as the duration of disability in patients with thoracic or lumbar vertebral fractures;
* to compare the results of surgical and conservative treatment methods in patients with thoracic or lumbar vertebral fractures.

The research focus will be on patients diagnosed with uncomplicated fractures of the thoracic and lumbar spine, classified as type A2 and A3 according to the AOSpine classification.

Two patient groups will be formed:

The main group (prospective) will consist of patients who underwent conservative therapy. The expected number of observations in the main group will be 40 patients.

The control group (historical control) will be comprised of 40 patients who underwent surgery previously at the Sklifosovsky Research Institute for Emergency Medicine.

The first stage of conservative therapy will be administered within 7 days at the departments of the Sklifosovsky Research Institute for Emergency Medicine. Subsequently, the patient will be transferred to a rehabilitation center for the second stage of conservative treatment at Branch No. 3 of the State Autonomous Healthcare Institution "Moscow Scientific and Practical Center for Medical Rehabilitation, Restorative and Sports Medicine". The third stage of medical rehabilitation will be carried out at outpatient healthcare facilities based on the patient's place of residence.

The study will be considered complete when the data from the final examination of at least 50 patients in each group have been analyzed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Thoracic Spine Fracture Lumbar; Spine, Fracture Thoracolumbar Burst Fracture Fracture of Spine, Level Unspecified Spine Fusion Spine Fracture

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Conservative treatment group

The main group (prospective) will consist of patients who received conservative therapy. The expected number of observations in the main group will be 50 patients.

rehabilitation treatment

Intervention Type OTHER

3-month immobilization period, hyperextension braces for specific fractures, therapeutic exercises, and gradual activity restoration.

Surgical treatment group

The control group (historical control) will be comprised of 50 patients who underwent surgery previously at the Sklifosovsky Research Institute for Emergency Medicine.

Spine fusion

Intervention Type PROCEDURE

Pedicle screw fixation or fusion; anterior plate fusion

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

rehabilitation treatment

3-month immobilization period, hyperextension braces for specific fractures, therapeutic exercises, and gradual activity restoration.

Intervention Type OTHER

Spine fusion

Pedicle screw fixation or fusion; anterior plate fusion

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 18 to 65 years.
* Isolated fracture of a single thoracic or lumbar vertebra, classified as type A2 or A3 according to the AOSpine classification.
* Absence of clinical evidence of nerve root or spinal cord compression at the injury level.
* Degree of spinal canal space narrowing less than 50% based on CT scans.
* Informed consent to participate in the study.

Exclusion Criteria

* Sagittal imbalance (Type 4 by C. Barrey).
* Vertebral bone density at the injury level less than 100 HU or osteoporosis exceeding grade 3 in vertebral bodies, pelvic bones, and limbs.
* Previous spinal surgeries.
* Anesthesia risk of 4 or 5 according to ASA.
* Acute exacerbation and decompensation of somatic diseases.
* Malignant tumors at any site.
* Systemic connective tissue disorders.
* Cognitive impairments hindering patient communication.
* Floating and mural thrombosis, regardless of location.
* Newly identified and uncorrectable cardiac rhythm disorders.
* Dizziness.
* Consequences of a previous acute cerebrovascular event.
* Pregnancy at any stage.
* Acute infectious diseases.
* History of fractures of the pelvis, lower limbs, or vertebral bodies.
* Congenital spinal and limb disorders.
* Any conditions contraindicating physiotherapeutic procedures.
* Patient refusal to participate in the study.
* Inability to participate in follow-up examinations for one year after the injury.
* Participation in other clinical trials.
* Absence of a signed informed voluntary consent for medical interventions and processing of personal data or personal data processing.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sklifosovsky Institute of Emergency Care

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ivan Lvov, MD, PhD

neurosurgeon

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Andrey Grin, MD, PhD

Role: STUDY_CHAIR

Sklifosovsky Research Institute for Emergency Medicine

Aleksandr Talypov, MD, PhD

Role: STUDY_DIRECTOR

Sklifosovsky Research Institute for Emergency Medicine

Vasiliy Karanadze, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Sklifosovsky Research Institute for Emergency Medicine

Ivan Lvov, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Sklifosovsky Research Institute for Emergency Medicine

Anton Kordonskiy, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Sklifosovsky Research Institute for Emergency Medicine

Iren Pogonchenkova, MD, PhD

Role: STUDY_CHAIR

Moscow Scientific and Practical Center for Medical Rehabilitation, Restorative and Sports Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sklifosovsky Research Institute for Emergency Medicine

Moscow, , Russia

Site Status

Moscow Scientific and Practical Center for Medical Rehabilitation, Restorative and Sports Medicine

Moscow, , Russia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Russia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1-28-08/2023

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

LUMBAR & SACROILIAC FUSION STUDY
NCT07204288 RECRUITING NA
Artoss Prospective Spine Registry Outcomes
NCT04439032 ACTIVE_NOT_RECRUITING
Fusion Status After ACDF
NCT05986006 UNKNOWN NA
Spine Trauma in the Elderly
NCT06019572 COMPLETED